Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Review and Preview01:10

Review and Preview

8.4K
In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.4K
Review and Preview01:13

Review and Preview

11.1K
Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.1K
Trait and State Self-Esteem02:08

Trait and State Self-Esteem

11.5K
The term self-esteem is often used generically, to refer to how people feel about themselves. However, according to research, there are three distinct constructs that should not be used interchangeably (Brown & Marshall, 2006). 
11.5K
Polygenic Traits01:18

Polygenic Traits

69.0K
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
69.0K
Epistasis01:39

Epistasis

50.1K
In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...
50.1K
Vaccinations01:51

Vaccinations

51.5K
Overview
51.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid identification of the predominant azole-resistant genotype in Candida tropicalis.

FEMS yeast research·2024
Same author

A predominant genotype of azole-resistant Candida tropicalis clinical strains.

The Lancet. Microbe·2022
Same author

China: The Next Pharmacy of the World?

Trends in pharmacological sciences·2018
Same author

Patent trend and competitive analysis of cancer immunotherapy in the United States.

Human vaccines & immunotherapeutics·2017
Same author

Role of PARL-PINK1-Parkin pathway in adipocyte differentiation.

Metabolism: clinical and experimental·2017
Same author

NMD Classifier: A reliable and systematic classification tool for nonsense-mediated decay events.

PloS one·2017
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026
See all related articles

Related Experiment Video

Updated: Jan 27, 2026

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro
10:36

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro

Published on: January 9, 2018

7.6K

Inter Partes Review: Patent Killer No More?

Feng-Chi Chen1, Pin-Shen Lee2

  • 1Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Miaoli County, Taiwan; School of Law, National Chiao Tung University, Hsinchu, Taiwan; School of Dentistry, China Medical University, Taichung, Taiwan.

Trends in Biotechnology
|March 21, 2019
PubMed
Summary
This summary is machine-generated.

Changes to the Inter Partes review (IPR) system are reshaping drug patent invalidation. These shifts impact strategic advantages for follow-on drug manufacturers and the broader biopharmaceutical industry.

Keywords:
Biologics Price Competition and Innovation ActHatch-Waxman ActInter partes reviewpatent infringement

More Related Videos

How to Calculate and Validate Inter-brain Synchronization in a fNIRS Hyperscanning Study
05:33

How to Calculate and Validate Inter-brain Synchronization in a fNIRS Hyperscanning Study

Published on: September 8, 2021

7.4K
Analysis of Human Natural Killer Cell Metabolism
09:03

Analysis of Human Natural Killer Cell Metabolism

Published on: June 22, 2020

7.4K

Related Experiment Videos

Last Updated: Jan 27, 2026

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro
10:36

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro

Published on: January 9, 2018

7.6K
How to Calculate and Validate Inter-brain Synchronization in a fNIRS Hyperscanning Study
05:33

How to Calculate and Validate Inter-brain Synchronization in a fNIRS Hyperscanning Study

Published on: September 8, 2021

7.4K
Analysis of Human Natural Killer Cell Metabolism
09:03

Analysis of Human Natural Killer Cell Metabolism

Published on: June 22, 2020

7.4K

Area of Science:

  • Pharmaceutical law and policy
  • Intellectual property rights in drug development
  • Biopharmaceutical industry analysis

Background:

  • Inter Partes Review (IPR) has been a key mechanism for challenging and invalidating drug patents.
  • IPR proceedings offer strategic advantages to companies developing generic or biosimilar drugs.
  • Recent modifications to the IPR system signal a significant alteration in its application and impact.

Purpose of the Study:

  • To summarize recent major changes to the Inter Partes Review (IPR) system.
  • To discuss the implications of these IPR system changes for the biopharmaceutical community.
  • To provide insights into the evolving landscape of drug patent challenges.

Main Methods:

  • Review of recent legislative and judicial decisions impacting the IPR process.
  • Analysis of the strategic implications of these changes for patent holders and generic/biosimilar manufacturers.
  • Synthesis of information to forecast future trends in drug patent litigation.

Main Results:

  • Identification of key modifications in IPR procedures and eligibility criteria.
  • Assessment of how these changes affect the likelihood of successful patent invalidation.
  • Evaluation of the potential impact on market entry timelines for follow-on drugs.

Conclusions:

  • The recent alterations to the IPR system represent a significant shift, potentially altering the balance of power in drug patent disputes.
  • Biopharmaceutical companies must adapt their strategies to navigate the evolving IPR landscape.
  • Understanding these changes is crucial for both innovator and generic/biosimilar drug developers to leverage or defend intellectual property effectively.